New Research On Reductil Mechanisms
Written by Stuart Stevens | Thursday, 20 July 2006 | There are 0 comments
Research has been done recently on the mechanisms of how exactly weight loss drugs and appetite suppressants work. The researchers looked at the active ingredients in for example the weight loss drug Reductil and saw that the sibutramine has a double effect on the appetite by acting on the chemical found in the brain called serotonin. The research was done using laboratory mice that had been bred to be genetically obese or lean.
The scientists from the University of Texas whose study is published in the journal Neuron, saw that serotonin in the brain works on neurons that suppress appetite and concurrently block other neurons that are designed to boost appetite.
The research is very important as it gives weight loss scientists a better understanding of how the Reductil and other weight loss drugs actually work and function. With this research the knowledge of molecular circuitry controlling body weight in reaction to the levels of serotonin in the brain is becoming clearer and this could lead to safer and more effective drugs to beat obesity.
Reductil is a very popular weight loss drug and goes by the name of Meridia in the United States and in Canada. It can only be prescribed by doctors for people who have serious weight problems and a full medical history should be shown to your doctor before using it. Redusctil has some side effects that can cause heart problems in certain people and some consumer groups say that it should be taken off the market.
However others argue that the risk of heart disease and many other health problems is much higher when you are obese and so by not using Reductil you could be at more risk. The maker of Reductil, Abbott Laboratories says that if the guidelines are followed and you take care of your health the drug is very safe to use.


